CITIGROUP INC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 78 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$233,000
+1.7%
9,763
-37.8%
0.00%
Q4 2020$229,000
+172.6%
15,691
+165.9%
0.00%
Q3 2020$84,000
-75.6%
5,901
-74.7%
0.00%
Q2 2020$344,000
+421.2%
23,363
+44.9%
0.00%
Q1 2020$66,000
+3.1%
16,127
+21.2%
0.00%
Q4 2019$64,000
+45.5%
13,308
+84.5%
0.00%
Q3 2019$44,000
-55.6%
7,214
-52.5%
0.00%
Q2 2019$99,0000.0%15,203
+8.6%
0.00%
Q1 2019$99,000
+47.8%
13,995
+1.4%
0.00%
Q4 2018$67,000
-36.2%
13,796
-3.5%
0.00%
Q3 2018$105,000
+118.8%
14,298
+92.0%
0.00%
Q2 2018$48,000
+4700.0%
7,448
+2742.7%
0.00%
Q1 2018$1,000
-50.0%
262
-39.6%
0.00%
Q4 2017$2,0000.0%434
+173.0%
0.00%
Q3 2017$2,000
+100.0%
159
+43.2%
0.00%
Q2 2017$1,0000.0%111
-4.3%
0.00%
Q1 2017$1,000
-99.8%
116
-99.7%
0.00%
Q4 2016$452,000
+976.2%
36,926
+936.7%
0.00%
Q3 2016$42,000
+223.1%
3,562
+140.2%
0.00%
Q2 2016$13,000
-92.9%
1,483
-95.7%
0.00%
Q1 2016$184,000
+1740.0%
34,760
+2615.6%
0.00%
Q4 2015$10,000
-33.3%
1,280
-31.4%
0.00%
Q3 2015$15,000
-40.0%
1,866
-32.8%
0.00%
Q2 2015$25,000
-43.2%
2,778
-19.1%
0.00%
Q1 2015$44,000
-58.5%
3,432
-56.2%
0.00%
Q4 2014$106,000
+231.2%
7,834
+120.9%
0.00%
Q3 2014$32,000
+14.3%
3,546
+71.1%
0.00%
Q2 2014$28,000
-65.4%
2,073
-74.7%
0.00%
Q1 2014$81,000
-77.6%
8,188
-69.9%
0.00%
Q4 2013$362,000
+36100.0%
27,180
+47584.2%
0.00%
Q3 2013$1,00057
+62.9%
0.00%
Q2 2013$0350.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders